Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

New data on T cells' protective role suggests need for new approach to dengue vaccine design

As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design.

15 Apr 2013

Athletes with vocal cord disorder inappropriately treated for exercise-induced asthma

Athletes with a vocal cord disorder that restricts breathing are more likely to be misdiagnosed and inappropriately treated for exercise-induced asthma, according to research presented today at the Triological Society's 116th Annual Meeting.

15 Apr 2013

New study examines role of mast cells in development of idiopathic pulmonary fibrosis

Pulmonary fibrosis is a chronic, deadly disease that affects five million people worldwide. It is irreversible, its cause is poorly understood, and it has a median survival of only about 3 years.

15 Apr 2013

Ozone attacks lung surface fluids, causes severe respiratory problems

Research at Birkbeck, University of London uses world-leading neutron sources at ILL and ISIS to demonstrate ozone attacks on lung surface fluids.

12 Apr 2013

ACOEM provides tools, resources to help employers identify and respond to impact of COPD

Awareness campaign for the workplace provides tools and information on preventing and managing chronic obstructive pulmonary disease - the third leading cause of death in the U.S.

12 Apr 2013

Stigma of mental illness, a public health concern

An international study found that despite widespread acceptance that mental illness is a disease that can be effectively treated, a common "backbone" of prejudice exists that unfairly paints people with conditions such as depression and schizophrenia as undesirable for close personal relationships and positions of authority.

12 Apr 2013

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

Omeros Corporation today announced positive data in the most commonly used model for studying the clinical and pathological features of multiple sclerosis (MS), further advancing its development program of GPR17-targeting compounds for the treatment of MS. Compounds previously discovered by Omeros that inhibit GPR17, an orphan G protein-coupled receptor (GPCR) unlocked by Omeros, significantly improved function from experimental autoimmune encephalomyelitis (EAE) in mice.

11 Apr 2013

UTHealth study explores ways to reduce infant exposure to secondhand smoke

A study to investigate whether a hospital-initiated behavioral therapy program conducted in the neonatal intensive care unit can reduce secondhand smoke in homes with infants at risk for pulmonary problems has been launched by researchers at The University of Texas Health Science Center at Houston.

11 Apr 2013

New national study examines marijuana use and prescription drug misuse

Individuals who use marijuana recreationally are more likely to misuse other drugs, including pain-controlling, but potentially addictive narcotics, sedatives and other prescription medications, than individuals who do not use marijuana, according to a new national study issued today by Quest Diagnostics, the world's leading provider of diagnostic information services.

From Quest Diagnostics 9 Apr 2013

New study shows exposure to tobacco smoke could negatively impact adolescent kidney function

Exposure to tobacco smoke could negatively impact adolescent kidney function; this is according to a new study led by a team of researchers at the Johns Hopkins Bloomberg School of Public Health and the Johns Hopkins Children's Center.

9 Apr 2013

AstraZeneca reports fostamatinib Phase 3 study results for treatment of rheumatoid arthritis

AstraZeneca today announced top-line results of OSKIRA-1, a Phase 3 study to assess the efficacy and safety of fostamatinib, the first oral spleen tyrosine kinase inhibitor in development for rheumatoid arthritis.

6 Apr 2013

MyAllergyTest kit allows allergy sufferers to test themselves against 10 key allergens

According to the American College of Allergy, Asthma and Immunology, more than 60 million Americans suffer from allergies. However, most people don't get tested for allergies, so they often do not know for certain what causes their allergies.

6 Apr 2013

Walgreens to expand health care services to include treatment of chronic illness

The retail chain becomes the first to offer such extensive primary care through nurse practitioners and physician assistants at more than 300 in-store clinics in 18 states.

5 Apr 2013

Walgreens' Take Care Clinics expand access to health care services

Access to health care services is an ongoing challenge to the U.S. health care system. With a physician shortage, aging population, a growing prevalence of chronic diseases and up to 30 million people projected to gain insurance coverage in 2014 through the Affordable Care Act, the issue will become even more critical - and may further impact both patients and the health care system at large.

4 Apr 2013

First Edition: April 4, 2013

Kaiser Health News staff writer Julie Appleby, working in collaboration with USA Today, reports: "It's not just sore throats and flu shots anymore. Walgreens today became the first retail store chain to expand its health care services to include diagnosing and treating patients for chronic conditions such as asthma, diabetes and high cholesterol. The move is the retail industry's boldest push yet into an area long controlled by physicians, and comes amid continuing concerns about health care costs and a potential shortage of primary care doctors" (Appleby, 4/4).

4 Apr 2013

Study: Two-thirds of asthmatics also have allergy

Asthma is becoming an epidemic in the United States. The number of Americans diagnosed with asthma grows annually, with 26 million currently affected. And according to a new study, nearly two-thirds or more of all asthmatics also have an allergy, which can make this spring season particularly bothersome.

2 Apr 2013

HAP caused by exposure to biomass fuels increases mortality risk

Almost four million people die each year from household air pollution (HAP) caused by exposure to the combustion of biomass fuels (wood, charcoal, crop residues, and dung), kerosene, or coal.

2 Apr 2013

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

N30 Pharmaceuticals, Inc., a clinical stage, biopharmaceutical company focused on the development of therapies for cystic fibrosis, announced today the presentation of key preclinical data for its novel inhibitors of S-nitrosoglutathione reductase.

2 Apr 2013

IDIBELL signs agreement with Histocell to use patent for acute pulmonary diseases with stem cells

The Bellvitge Biomedical Research Institute has signed a licensing agreement with the Spanish biotech company Histocell to make use of a patent for the treatment of acute pulmonary diseases with mesenchymal stem cells.

28 Mar 2013

Researcher discovers genetic variations that are linked to breast cancer

Working with an international consortium conducting research on breast, ovarian and prostate cancer among 200,000 people, Professor Jacques Simard, holder of the Canada Research Chair in Oncogenetics at Laval University, was actively involved in the discovery of DNA "spelling mistakes" linked to breast cancer.

28 Mar 2013

Asthma News and Research

Further Reading

New data on T cells' protective role suggests need for new approach to dengue vaccine design

Athletes with vocal cord disorder inappropriately treated for exercise-induced asthma

New study examines role of mast cells in development of idiopathic pulmonary fibrosis

Ozone attacks lung surface fluids, causes severe respiratory problems

ACOEM provides tools, resources to help employers identify and respond to impact of COPD

Stigma of mental illness, a public health concern

Omeros' GPCR platform unlocks new drug targets against multiple sclerosis

UTHealth study explores ways to reduce infant exposure to secondhand smoke

New national study examines marijuana use and prescription drug misuse

New study shows exposure to tobacco smoke could negatively impact adolescent kidney function

AstraZeneca reports fostamatinib Phase 3 study results for treatment of rheumatoid arthritis

MyAllergyTest kit allows allergy sufferers to test themselves against 10 key allergens

Walgreens to expand health care services to include treatment of chronic illness

Walgreens' Take Care Clinics expand access to health care services

First Edition: April 4, 2013

Study: Two-thirds of asthmatics also have allergy

HAP caused by exposure to biomass fuels increases mortality risk

N30 Pharmaceuticals presents preclinical data of GSNORi at European Cystic Fibrosis Society meeting

IDIBELL signs agreement with Histocell to use patent for acute pulmonary diseases with stem cells

Researcher discovers genetic variations that are linked to breast cancer

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News